Literatur
-
1
Bower M, Palmieri C, Dhillon T.
AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy.
Curr Opin Infect Dis.
2006;
19
14-19
-
2
Sgadari C. et al .
HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma.
Nat Med.
2002;
8
225-232
-
3
Crane H M. et al .
Fatal Kaposi’s sarcoma-associated immune reconstitution following HAART initiation.
Int J STD AIDS.
2005;
16
80-83
-
4
Stebbing J. et al .
The presentation and survival of patients with non-cutaneous AIDS-associated Kaposi’s sarcoma.
Ann Oncol.
2006;
17
503-506
-
5
Jabr F I.
Acquired immunodeficiency syndrome-related Kaposi’s sarcoma of the axilla and breast after percutaneous intravenous catheter insertion.
Int J Dermatol.
2005;
44
611-612
-
6
Di Lorenzo G. et al .
Management of AIDS-related Kaposi’s sarcoma.
Lancet Oncol.
2007;
8
167-176
Dr. med. Frank Grünhage
Medizinische Klinik und Poliklinik I
Universitätsklinik Bonn
Sigmund-Freud-Straße 25
53105 Bonn
eMail: Frank.Gruenhage@ukb.uni-bonn.de
